InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Gilman Steven C, Director. Officer active across 3 companies, notably Akebia Therapeutics, Inc.. Cumulatively, 22 filings have been logged. Split: 0 buy · 3 sells. Total volume traded: €40k. Activity tracked since 2 June 2021. The latest transaction was filed on 26 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gilman Steven C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
23,000 shares0Common stockSEC:0000950170-25-091562:0
35,700 shares0Common StockSEC:0001562180-25-004719:0
5,833 shares@ US$13.0520.1% of flowCommon StockSEC:0001140361-24-043695:0
5,833 shares@ US$13.0519.8% of flowCommon StockSEC:0001140361-24-042882:0
5,834 shares@ US$13.0519.7% of flowCommon StockSEC:0001140361-24-041562:0
5,000 shares@ US$3.744.8% of flowCommon StockSEC:0001140361-24-040228:0
23,000 shares0Common StockSEC:0000950170-24-076235:0
30,000 shares0Common StockSEC:0001562180-24-004906:0
3,200 sharesCommon StockSEC:0001140361-24-024332:0
10,000 shares0Common StockSEC:0000950170-23-029622:0
30,000 shares0Common StockSEC:0001562180-23-004954:0
2,600 sharesCommon StockSEC:0001140361-23-021499:0
10,000 shares0Common StockSEC:0001209191-22-038657:0
13,700 shares0Common StockSEC:0001562180-22-004975:0
4,567 shares@ US$0.3620.0005% mcap5.8% of flowCommon StockSEC:0001562180-22-004870:0
900 shares@ US$30.940.0016% mcap21.3% of flowCommon StockSEC:0001593968-22-000897:0
2,600 sharesCommon StockSEC:0001593968-22-000891:0
5,000 shares@ US$3.745.5% of flowCommon StockSEC:0001593968-21-002478:0
5,000 shares@ US$3.745.4% of flowCommon StockSEC:0001593968-21-002304:0
5,000 shares@ US$3.745.4% of flowCommon StockSEC:0001593968-21-002214:0
4,567 shares@ US$3.320289.0% of flowCommon StockSEC:0001562180-21-004152:0
13,700 shares0Common StockSEC:0001562180-21-004027:0
22 of 22 declarations
About Gilman Steven C
Administrator of Vericel Corp, Akebia Therapeutics, Inc. and SCYNEXIS INC, GILMAN STEVEN C has filed 22 forms in total. Across the 22 sampled filings, the period runs from 2021-06-03 to 2025-06-30, with EUR 0 of buys and EUR 40483 of sells, and the most frequent transaction nature is Levée d'options.
